Fig. 6From: An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancerHs578T (A-F) and BT549 (G-L) cell migration was monitored over 24 h after the addition of Hs578Ts(i)8-derived EVs following cell treatment with drugs/compounds. Control EVs are EVs released from untreated cells. Closure of the wound was measured using ImageJ. Amount of EVs added were dependent on the cell density for each recipient cell line. Graphs represent mean ± SEM of n = 3 independent experiments. Student’s t-test was used as statistical test. *P < 0.05Back to article page